Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters










Database
Type of study
Language
Publication year range
1.
Acta Biomed ; 85(3): 281-4, 2014 Dec 17.
Article in English | MEDLINE | ID: mdl-25567468

ABSTRACT

Neuroleptic Malignant-Like Syndrome (NMLS) is a rare, but potentially fatal complication of dopaminergic therapy in Parkinson's disease due to a sudden withdrawal of dopaminergic therapy. Here, we describe the case of a 79 years old woman, with 19 years history of Parkinson disease treated with L-dopa, dopamine agonists and MAO inhibitors, whose sudden withdrawal due to lack of therapeutic compliance, led to sudden onset of high fever, muscle rigidity, akinesia, autonomic dysfunction, impaired level of consciousness, respiratory distress and dysphagia with inability to take oral dopaminergic therapy. High blood levels of CPK and myoglobinaemia were found. The patient was treated with transdermal Rotigotine starting from a dose of 2 mg/24 hours, that was rapidly increased to 6 mg/24 hours, leading to resolution of the acute disturbances.


Subject(s)
Levodopa/adverse effects , Neuroleptic Malignant Syndrome/drug therapy , Parkinson Disease/drug therapy , Tetrahydronaphthalenes/therapeutic use , Thiophenes/therapeutic use , Aged , Antiparkinson Agents/adverse effects , Antiparkinson Agents/therapeutic use , Antipsychotic Agents , Dopamine Agonists/therapeutic use , Female , Humans , Levodopa/therapeutic use , Neuroleptic Malignant Syndrome/etiology
SELECTION OF CITATIONS
SEARCH DETAIL
...